Company Profile For Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. (Bioniche) is a Canadian biopharmaceutical company. The Company develops, manufactures, and markets products for human and animal health markets worldwide. It operates in three segments: human health, animal health, and food safety. The human health business unit of the Company operated through Bioniche Therapeutics, which develops human cancer therapies, with a focus on the research and development of the Company’s Mycobacterial Cell Wall-DNA Complex (MCC) technology platform for the treatment of bladder and other cancers, and its oligonucleotides, which show pre-clinical promise in the treatment of leukemia and other cancers. The Company’s animal health business unit develops, manufactures and markets animal health biopharmaceutical products worldwide. Its food safety business unit is engaged in researching, developing, manufacturing and marketing of veterinary biopharmaceutical products to help improve the safety of food and water supplies.

BRIEF: For the fiscal year ended 30 June 2009, Bioniche Life Sciences Inc.'s revenues increased 21% to C$33.3M. Net loss decreased 35% to C$10.5M. Revenues reflect increased sales from animal Health Foods segment. Lower loss reflects lower administration expenses, lower research & development expenses, presence of foreign exchange gain vs. loss, higher gross margin, decreased operating loss and lower marketing & selling expense.